Dr. Azab completed his Ph.D. in pharmacology in the Department of Clinical Pharmacology in Ben-Gurion University of the Negev (Israel), focusing on the study of anti-inflammatory drugs. Subsequently, as a post-doctoral fellow in Wayne State University (Michigan), Dr. Azab investigated the mechanisms of mood-stabilizing drugs, focusing on the role of GSK-3 in inositol biosynthesis. Currently, Dr. Azab is an assistant professor in Ben-Gurion University of the Negev. Major research projects in his lab: studying the role of inflammation in the pathophysiology and treatment of mood disorders; searching for novel therapeutic strategies for mood disorders.
